IMP
Process View
negative regulation of bone remodeling
Any process that stops, prevents, or reduces the frequency, rate or extent of bone remodeling.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative regulation of bone remodeling"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.373 | ||
| NRP1 | neuropilin 1 | 0.077 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.046 | ||
| SH3KBP1 | SH3-domain kinase binding protein 1 | 0.030 | ||
| PGF | placental growth factor | 0.030 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.020 | ||
| IL4R | interleukin 4 receptor | 0.020 | ||
| EPOR | erythropoietin receptor | 0.018 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.016 | ||
| SLAMF1 | signaling lymphocytic activation molecule family member 1 | 0.012 | ||
| PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.011 | ||
| FCGR2B | Fc fragment of IgG, low affinity IIb, receptor (CD32) | 0.011 | ||
| PDCD6IP | programmed cell death 6 interacting protein | 0.010 | ||
| ATP2B2 | ATPase, Ca++ transporting, plasma membrane 2 | 0.010 |